Curriculum vitae matthew ryan weir, M. D



Download 0.51 Mb.
Page6/7
Date conversion04.02.2017
Size0.51 Mb.
1   2   3   4   5   6   7
PRESENTATIONS, SPEECHES AND GRAND ROUNDS

  1. Weir MR, Cohen, D.J., Carpenter, C.B. Compartmentalization of the immune response to repetitive stimulation with alloantigen. American Federation for Clinical Research. October, 1983.

  2. Weir MR, Cohen, D.J., Carpenter, C.B. Allograft transplantation subsequent to active and passive enhancement leads to compartmentalization of the immune response. American Federation for Clinical Research. October, 1983.

  3. Weir MR, Kirkman, R.L., Strom, T.B., Tilney, N.L. Chronic liver disease in recipients of long-term renal allografts: Analysis of morbidity and mortality. American Society of Nephrology. December, 1983.

  4. Weir MR, Cohen, D.J., Carpenter, C.B. Dissimilar immune responses to varied presentation of identical alloantigens. International Society of Nephrology. June, 1984.

  5. Weir MR, Kirkman, R.L., Strom, T.B. The long-term effects of hepatitis B virus in renal transplant recipients: Analysis of morbidity and mortality. International Congress of the Transplantation Society. August, 1984.

  6. Weir MR, Josselson, J., Sadler, J.H. Bi-weekly vs. thrice-weekly hemodialysis: Five year analysis of morbidity and mortality. American Society of Nephrology. December, 1984.

  7. Medical Grand Rounds: Maryland General Hospital. "Use of Cyclosporine in Transplantation Today." September, 1983.

  8. Nephrology Grand Rounds: Baltimore City Hospital. "Use of HLA-typed apheresis byproducts as alloenhancing agents in prospective renal transplant recipients." December, 1983.

  9. Medical Grand Rounds: Waterbury Hospital, CT. "Use of Cyclosporine in Renal Transplantation." January, 1984.

  10. Nephrology Grand Rounds: Yale-New Haven Hospital. "Cyclosporine as an immunomodulatory of the mixed lymphocyte reaction." January, 1984.

  11. Medical Grand Rounds: Southern Maryland Hospital. "Newer agents in the treatment of hypertension." May, 1984.

  12. Nephrology Grand Rounds: The Johns Hopkins Hospital. "Rat model of Cyclosporine Nephrotoxicity." May, 1984.

  13. Medical Grand Rounds: Southern Maryland Hospital. "Newer agents in the treatment of hypertension." May, 1984.

  14. Medical Grand Rounds: Perry Point V.A. Hospital. "Hypertension Update: 1984." September, 1984.

  15. Nephrology Grand Rounds: Francis Scott Key Hospital. "Comparison Study of Bi-weekly vs. thrice-weekly hemodialysis." November, 1984.

  16. Medical Grand Rounds: Union Memorial Hospital. "Controversies in Anti-hypertensive Therapy." December, 1984.

  17. Medical Grand Rounds: Rutgers/New Jersey Medical School. "Immunologic Basis of Action of Cyclosporine." December, 1984.

  18. WBJC Radio. Discussion of the use of cyclosporine in renal transplantation. January 1985.

  19. Medical Grand Rounds: Church Home Hospital. "Newer agents in the treatment of hypertension." February, 1985.

  20. Medical Housestaff Conference: Prince George's General Hospital. "Management of Hypertension in 1985." February, 1985.

  21. Medical Grand Rounds: Mercy Hospital. "Use of Cyclosporine in Organ Transplantation." March 1985.

  22. Medical Grand Rounds: Doctor's Hospital. "Electrolyte Disorders." May, 1985.

  23. Housestaff Medical Conference: Greater Baltimore Medical Center. "Acid-Base Disorders." June, 1985.

  24. 11th Annual Family Medicine Review Course, Ocean City, Maryland. "Are Thiazides Still Appropriate for Hypertension." June, 1985.

  25. Medical Grand Rounds: Harford Memorial Hospital. "Treatment of Hypertension in the Elderly." August, 1985.

  26. Medical Staff Basic Science Lecture: Greater Baltimore Medical Center. "Pathogenesis and treatment of hypertension in the elderly." August, 1985.

  27. Housestaff Medical Conference: Mercy Hospital. "Renal Transplantation and Immunosuppression." September, 1985.

  28. Invited Speech at Semiannual Meeting of the Medical and Chirurgical Faculty of Maryland. "Extrapulmonary Tuberculosis in a Community Hospital Experience." Bermuda, September, 1985.

  29. Medical Grand Rounds: Kirk Army Hospital. "Treatment of hypertension in the elderly." September, 1985.

  30. Cyclosporine Symposium: Practical, Clinical and Economic issues in the cyclosporine-treated patient. Panelist and speaker. Chicago, IL. September, 1985.

  31. Medical Grand Rounds: Fallston General Hospital. "Newer Agents in the Treatment of Hypertension." September, 1985.

  32. Medical Grand Rounds: Mercy Hospital, "Extrapulmonary Tuberculosis." October, 1985.

  33. Medical Grand Rounds: St. Joseph's Hospital. "Are Thiazides Still Relevant in Treatment of Hypertension." October,1985.

  34. Invited Panelist in National Conference: "Clinical Management of the Renal Transplant Recipient Treated with Cyclosporine." Palm Beach Florida, November, 1985.

  35. Medical Grand Rounds: Peninsula General Hospital. "Newer Agents in the Treatment of Hypertension." November, 1985.

  36. Invited Speaker: Symposium on Medical Update, Harford Memorial Hospital. "Organ Transplantation: Update." November, 1985.

  37. Weir MR "Acute Effects of Hemodialysis on Lymphocyte Subpopulations and Response to PHA." Presentation at Joint Session National Kidney Foundation American Society of Nephrology, December, 1985.

  38. Medical Grand Rounds: Waterbury Hospital Health Center. "Newer Developments in the Treatment of Hypertension." December, 1985.

  39. Housestaff Medical Conference: Mercy Hospital. "Hypertension Update, 1986." January, 1986.

  40. Invited Speaker: Constant Care Medical Center. "Evaluation and Treatment of Hypertension." March, 1986.

  41. Invited Visiting Professorship and Medical Grand Rounds, Hahnemann University Hospital, Philadelphia, Pennsylvania. "Never Insights into Immunosuppressive Therapy in Organ Transplantation." March, 1986.

  42. Invited Speaker: AMA of Southern New Jersey. "Calcium Channel Blockers and their use in hypertension today." March, 1986.

  43. Columbus, Eldersburg, MD. "Hypertension Evaluation and Detection." March, 1986.

  44. Medical Grand Rounds: Perry Point VA Hospital. "Hypertension Update-Transcutaneous Delivery Systems." May, 1986.

  45. Weir MR Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pre-transplant immunity. American Society of Transplant Physicians, Chicago, IL. May, 1986.

  46. Medical Conference: Greater Baltimore Medical Center. "Hypertension Update-Transcutaneous Delivery Systems." June, 1986.

  47. Medical Grand Rounds: Howard University Hospital, Washington D.C. "Update in Hypertension, 1986." June, 1986.

  48. Medical Conference: Pentagon Army Medical Clinic. "Update in Hypertensive Therapy-Focus on Blood Lipids." August, 1986.

  49. Weir MR, Irwin, B.C., Maters, A.W., Genemans, G., Shen, S.Y., Charache, P., Williams G.M. Morbid outcome of cytomegalovirus-negative transplant recipients receiving cytomegalovirus-positive kidneys. XI International Congress of the Transplantation Society, August, 1986, Helsinki, Finland (Presented).

  50. Weir MR, Shen, S.Y., Dagher, F.J., Bentley, F.R., Sadler, J.H. A short term analysis of the effect of cyclosporine and source leukocyte transfusions on the cytotoxic antibody production of highly sensitized prospective renal transplant recipients. XI International Congress of the Transplantation Society, August, 1986 Helsinki, Finland (Presented).

  51. Invited Presentation: Annual Meeting of the Virginia Academy of Family Practice, Vienna, Virginia. "Newer Strategies in Anti-hypertensive Therapy: 1986." September, 1986.

  52. WNTR Radio. Discussion about What's New in Transplantation. September, 1986.

  53. Medical Conference: University of Louisville, Louisville, KY. "Importance of Quality of Life and Side Effects in Anti-Hypertensive Therapy." October, 1986.

  54. Medical Conference: Eastern Shore Hospital, Cambridge, MD. "Acid-Base and Electrolyte Disorders," October, 1986.

  55. Visiting Professor of the People to People Citizen Ambassador Program to the People's Republic of China. Conferences and Lectures on organ transplantation and treatment of hypertension at: the Beijing Friendship Hospital, Peking Union Medical College in Beijing, and the Jinling Hospital in Nanjing. October, 1986.

  56. Medical Conference and Visiting Professor at the University of Iowa Hospital, Iowa City, IA. "The effects of Calcium Channel Blockade on Lymphocyte Activation and Function." November, 1986.

  57. Invited Speaker: Investigator's Meeting for the "Verapamil vs Captopril vs Atenolol in Hypertensive Blacks," study at Hilton Head, S.C. "Hemodynamic effects of Verapamil, Captopril and Atenolol in Hypertensives." November, 1986.

  58. Medical Conference: Physician's Memorial Hospital, LaPlata, MD. "Acid-Base and Electrolyte Disorders." November, 1986.

  59. Weir MR, Peppler, R., Handwerger, B.S., Inhibition of human peripheral blood mononuclear cell function by Verapamil. American Society of Nephrology, Washington, D.C., December, 1986.

  60. Medical Grand Rounds: Union Hospital, Cecil, MD. "Update in Organ Transplantation." January, 1987.

  61. Research Conferences and Visiting Professor: Wayne State University, Detroit, MI "Use of calcium channel blockers in organ transplantation" and "A physiologic approach to the control of blood pressure while maintaining organ perfusion," February, 1987.

  62. Medical Grand Rounds: Beltsville Hospital, Laurel, MD. "Update in anti-hypertensive therapy, 1987." February, 1987.

  63. Medical Grand Rounds: Mercy Hospital, Baltimore, MD. "A physiologic approach to the control of blood pressure while maintaining organ perfusion." March, 1987.

  64. Research Conferences and Visiting Professor: University of Cincinnati Medical Center, Cincinnati, OH. "Use of calcium channel blockers in hypertension and as immunomodulatory agents." March, 1987.

  65. Research Conferences and Visiting Professor: The Cleveland Clinic Foundation, Cleveland, OH. "Use of calcium channel blockers in hypertension and as immunomodulatory agents." March, 1987.

  66. Weir MR, Josselson, J., Hebel, J.R., Sadler, J.H., Saunders, E. "End-stage Renal Disease secondary to hypertension: 5 year analysis of morbidity and mortality." Presentation at the Second International Interdisciplinary Conference on Hypertension in Blacks. March, 1987.

  67. Invited speaker at Symposium preceding American College of Cardiology, Tulane University School of Medicine. "Expanding Options in Hypertension Therapy: Calcium Channel Blockers." New Orleans, La. March, 1987.

  68. Invited speaker at symposium of Maryland Academy of Family Practice: "Use of ACE Inhibitor and calcium channel blockers in the treatment of hypertension." Easton, MD, March, 1987.

  69. Medical Grand Rounds: Riverside Hospital, Newport News, Va. "A physiologic approach to the control of blood pressure while maintaining organ perfusion." April, 1987.

  70. Medical Grand Rounds: Doctor's Hospital, Prince George, MD. "Electrolyte Disorders a simplified approach." April, 1987.

  71. Medical Research Conference: Cedars-Sinai Medical Center, Miami, FL. "Physiology of anti-hypersensitivity and how to achieve blood pressure control." May, 1987.

  72. Moderator and speaker, Symposium: "Focus on Ace Inhibitors." Baltimore, MD, May, 1987.

  73. Weir MR Presentation at American Society of Transplant Physicians, Chicago, IL: "Additive effect of cyclosporine and verapamil on the inhibition of the activation and function of human peripheral blood mononuclear cells." May, 1987.

  74. Weir MR Presentation of the American Society of Transplant Physicians, Chicago, IL: "Incidence and morbidity of cytomegalovirus disease in a seronegative recipient of seropositive donor specific transfusion and living relative donor transplantation: a multi-center evaluation." May, 1987.

  75. Medical Grand Rounds: Altoona V. A. Hospital, Altoona, Pa. "Newer approaches to the treatment of hypertension." June, 1987.

  76. Weir, MR. Presentation at International Society of Nephrology, London U.K. "Additive inhibition of verapamil and cyclosporine on lymphocyte activation." July, 1987.

  77. Invited Speaker: American Academy of Family Practice Annual Meeting. "Managing hypertension in modern family practice." San Francisco, CA, September, 1987.

  78. Invited Speaker: Church Home Hospital. "Renal-Electrolyte Disorders." October 1987.

  79. Invited Speaker: Broward General Hospital Medical Grand Rounds, Miami, FL. "Use of calcium antagonists in the treatment of hypertension." October, 1987.

  80. Invited Speaker: Waynesboro Hospital Grand Rounds, Waynesboro, PA. "Update in Organ Transplantation." October, 1987.

  81. Weir MR, Presentation at Second International Congress on Cyclosporine, Washington, D.C. "Additive Inhibition of human peripheral blood mononuclear cell-function by verapamil and cyclosporine." November, 1987.

  82. Invited Speaker: Latrobe Area Hospital Medical Grand Rounds, Latrobe, PA. Hypertension update: "Prevention of End-Organ Damage." November, 1987.

  83. Weir MR Presentation at the American Society of Nephrology 20th Annual Meeting. "Inhibition of verapamil and the activation and function of human peripheral blood mononuclear cells in additive with cyclosporine and may occur through calcium independent mechanisms." December 1987.

  84. Visiting Professor: Parkland Memorial Hospital, Dallas, TX. Medical Research Conferences: "Subcellular effects of verapamil and cyclosporine on calcium metabolism in lymphocytes" and "A physiologic approach to the control of blood pressure from a nephrologist's standpoint." January, 1988.

  85. Invited Speaker: Symposium preceding the American College of Cardiology. Topic: "Impact of high blood pressure on the kidney." Atlanta, Georgia. March, 1988.

  86. Plenary Session Speech: International Interdisciplinary Conference on Hypertension in Blacks. Topic: "Implication of high blood pressure on renal function." Baltimore, MD. April, 1988.

  87. Invited Speaker: Symposium on: "Newer aspects of cardiovascular therapy." Sponsored by The University of Massachusetts. "Renal aspects of antihypertensive therapy." Boston, MA. May, 1988.

  88. Weir MR Presentation at the American Society of Transplant Physicians 7th Annual Meeting. "Acute effects of cyclosporine on blood pressure, renal hemodynamics and urine prostaglandin production in healthy humans." Chicago, IL. May, 1988.

  89. Visiting Professor: Oregon Health Sciences University, Portland, OR. Medical Research Conferences: "Subcellular effects of verapamil and cyclosporine on calcium metabolism in lymphocytes" and "A physiologic approach to the control of blood pressure from a nephrologist's standpoint." June, 1988.

  90. Weir MR Presentation at the American Society of Hypertension 3rd Annual Meeting. "Effect of the thromboxane synthetase inhibitor CGS 13080 on blood pressure, renal hemodynamics and prostaglandin production in hypertensive humans" and "Efficacy and safety of nilvadipine in hypertension." New York, N.Y. June, 1988.

  91. Weir MR Research Lecture at the University of Mississippi Medical Center. "Impact of antihypertensive agents on renal hemodynamics: can they arrest the progression of renal disease?" July, 1988.

  92. Weir MR Medical Grand Rounds: St. Joseph's Hospital, Yonkers, N.Y. "A physiologic approach to the control of blood pressure: can it offer target organ protection?" July, 1988.

  93. Weir MR Medical Grand Rounds: Richmond V.A. Hospital, Richmond, Va. "Impact of antihypertensive therapy on target organ protection." August, 1988.

  94. Weir MR Two presentations at the XII International Congress of the Transplantation Society in Sydney, Australia. "Additive inhibitory effect of cyclosporine and verapamil may occur through independent mechanisms which may be dependent or independent of the slow calcium channel" and "The acute effects of intravenous cyclosporine on renal function in healthy humans." August, 1988.

  95. Weir MR Medical Grand Rounds: Maryland General Hospital, Baltimore, Maryland. "Evolving goals in the treatment of hypertension." September, 1988.

  96. Weir MR Presentation at a symposium at the American Academy of Family Practice, New Orleans, LA. "Target organ protection: impact of antihypertensive therapy on the kidney." October, 1988.

  97. Weir MR Medical Grand Rounds: Harrisburg Hospital, Harrisburg, PA. "Evolving goals in the treatment of hypertension with focus on target organ protection." October, 1988.

  98. Weir MR Medical Grand Rounds: Bedford V.A. Hospital, Bedford, MA. "Evolving goals in the treatment of hypertension." October, 1988.

  99. Weir MR Symposium: Sponsored by the Cleveland Clinic, Cleveland, OH. "Impact of antihypertensive therapy on the kidney: target organ protection." November, 1988.

  100. Weir MR Presentation at the 61st American Heart Association Meeting, Washington, D.C. "Effect of verapamil on renal hemodynamics in normotensives." November, 1988.

  101. Weir MR. Presentation at the 21st Annual Meeting of the American Society of Nephrology, San Antonio, Tx. "Mechanisms of additive inhibition of immunologic responses of cyclosporine and verapamil." December, 1988.

  102. Weir MR Medical Grand Rounds: Bronx VA Hospital, Bronx, N.Y. "Physiology of blood pressure control: focus on target organ protection." January, 1989.

  103. Weir MR Visiting Professor and Research Conferences: Miami VA Hospital and Jackson Memorial Hospital. "Impact of the effect of ACE inhibitors and calcium antagonists on target organ protection in the kidney."

  104. Weir MR Research Conference: Albert Einstein Medical Center, Bronx, N.Y. "Physiology of blood pressure control: focus on target organ protection."

  105. Weir MR Medical Grand Rounds: Oakland Naval Hospital, Oakland, CA. "Can we prevent target organ damage to the kidney." March, 1989.

  106. Weir MR Medical Conference: Bethesda Naval Hospital, Bethesda, MD. "A physiologic approach to blood pressure control while maintaining organ perfusion." March, 1989.

  107. Weir MR Medical Grand Rounds: Wilkes-Barre VA Hospital, Wilkes Barre, PA. "Magnesium deficiency: clinical implications." March, 1989.

  108. Weir MR Medical Grand Rounds: St. Joseph's Hospital, Pontiac, MI. "Target organ damage in hypertension: can we prevent it?" March, 1989.

  109. Medical Grand Rounds: Letterman Army Hospital, San Francisco, CA. "A physiologic approach to blood pressure control while maintaining organ perfusion," May, 1989.

  110. Weir MR Presentation at the 4th Annual Meeting of the American Society of Hypertension. "Comparison of the efficacy of atenolol, captopril and verapamil SR in hypertensive blacks." New York, N.Y., May, 1989.

  111. Weir MR Presentation at the 4th Annual Meeting of the American Society of Hypertension. "A multifactorial evaluation of the antihypertensive efficacy of the combination of diltiazem and hydrochlorothiazide." New York, N.Y., May, 1989.

  112. Weir MR Presentation at the 8th Annual Meeting of the American Society of Transplant Physicians. "Mechanisms of additive inhibition of immunological responses by verapamil and cyclosporine." Chicago, IL., May, 1989.

  113. Weir MR Presentation at the 8th Annual Meeting of the American Society of Transplant Physicians. "The acute effects of intravenous cremophor EL on blood pressure, renal hemodynamics and urine prostaglandin production of healthy humans." Chicago, IL., May, 1989.

  114. Invited Speaker: Maryland Academy of Family Practice Annual Meeting: Ocean City, Maryland. "Physiologic Approach to blood pressure control while maintaining organ perfusion." May, 1989.

  115. Weir MR Medical Grand Rounds: Washington Adventist Hospital, Washington, D.C. "A physiologic approach to blood pressure control while maintaining organ perfusion." June, 1989.

  116. Invited Speaker: "Hypertension Symposium," "Race as a variable factor in the management of hypertension." Hilton Head, S.C., June, 1989.

  117. Weir MR Medical Grand Rounds: National Rehabilitation Hospital, Washington, D.C. "Physiologic approach to blood pressure control while maintaining organ perfusion." June, 1989.

  118. Invited Speaker: National Medical Association Annual Meeting, Orlando, FL. "Physiology of blood pressure control in black hypertensives; impact on renal protection." July, 1989.

  119. Invited Speaker: Medical Grand Rounds, Sinai Hospital, Baltimore, MD: "The physiologic approach to blood pressure control while maintaining organ perfusion," September, 1989.

  120. Invited Speaker: Satellite Symposium of the American Academy of Family Practice. "Physiology of blood pressure control: implication for renal protection," Los Angeles, CA, September 1989.

  121. Invited Speaker: Medical Grand Rounds, Southern Maryland Hospital, LaPlata, MD: The physiology of blood pressure control." September, 1989.

  122. Invited Speaker: Medical Grand Rounds, Cumberland Memorial Hospital: "The physiologic approach to blood pressure control while maintaining organ perfusion," Cumberland, MD 1989.

  123. Invited Speaker: Renal Grand Rounds, Georgetown University: "The impact of blood pressure control on renal protection." October, 1989.

  124. Invited Speaker: Medical Grand Rounds, Liberty Medical Center: "Impact of blood pressure control on renal function." October, 1989.

  125. Invited Speaker: Renal Grand Rounds, Francis Scott Key Medical Center: "Impact of blood pressure control on renal function." November, 1989.

  126. Visiting Professor: UCLA, Los Angeles, CA. UCLA Nephrology Society: "The use of calcium antagonists in organ transplantation," Medical Grand Rounds,

  127. Sepulveda VA Hospital: "The physiologic approach to blood pressure control while maintaining organ perfusion," Nephrology Research Conference, Wadsworth VA Hospital: "Acid base and electrolyte disorders." November 1989.

  128. Invited Speaker: Nephrology Grand Rounds, University of Louisville, Louisville, KY: "Implications of blood pressure control on renal function." November 1989.

  129. Invited Speaker: Medical Grand Rounds, Monmouth Medical Center, Monmouth, N.J: "The physiologic approach to blood pressure control while maintaining organ perfusion." November 1989.

  130. Weir MR Presentation at the 22nd Annual Meeting of the American Society of Nephrology, Washington, D.C: "Immunosuppressive properties of enisoprost and SC-45662 (5-lipoxygenase inhibitor). December 1989.

  131. Weir MR Presentation at the 22nd Annual Meeting of the American Society of Nephrology, Washington D.C: "Tripterygium Wilfordii, a chinese herbal medicine with potent immunosuppressive properties." December 1989.

  132. Invited Speaker: Medical Grand Rounds, Brooke Army Medical Center, San Antonio, Tx: "Impact of blood pressure control in renal function." December 1989.

  133. Invited Speaker: Medical Grand Rounds, D.C., General Hospital, Washington, D.C.: "The physiologic approach to blood pressure control while maintaining organ perfusion." December 1989.

  134. Invited Speaker: Cardiology Grand Rounds, Yale New Haven Medical Center, New Haven, CT: "The physiology of blood pressure control: impact on vascular disease." January, 1990.

  135. Invited Speaker: Toronto General Hospital, Toronto, Canada: "Impact of blood pressure control on renal function." January 1990.

  136. Invited Speaker: Nephrology Research Conference, Vanderbilt University, Nashville, TN: "Impact of calcium channel blockade and inhibition of prostaglandin synthesis on the activation and function of peripheral blood lymphocytes." January, 1990.

  137. Invited Speaker: Nephrology Grand Rounds, Miami VA Hospital, Miami, Florida: "Calcium channel

  138. blockers in organ transplantation: Implications for therapy." February, 1990

  139. Invited Speaker: Medical Grand Rounds, Flushing Hospital, Flushing, N.Y.: "Hypertension in the elderly: an important concern," March, 1990.

  140. Invited Speaker: Interfaith Medical Center, Brooklyn N.Y: "Hypertension in the elderly."

  141. March, 1990.

  142. Invited Speaker: Satellite Symposium preceding the American College of Cardiology: "The impact of calcium blockade on lymphocyte activation and function. March, 1990.

  143. Invited Speaker: Research Grand Rounds, University of Indiana, Indianapolis, Indiana: "Impact of blood pressure control on renal function." April, 1990.

  144. Invited Speaker: Annual Meeting of the North Carolina Academy of Rheumatology, Raleigh, N.C: "Musculoskeletal symptomatology in dialysis and transplant patients." April, 1990.

  145. Invited Speaker: Medical Grand Rounds, University of Tennessee, Knoxville, TN. "The physiologic approach to blood pressure control while maintaining organ perfusion." April, 1990.

  146. Invited Speaker: Medical Grand Rounds, St. Joseph's Hospital, Towson, MD: "The implications of renal prostanoid synthesis on renal function." April, 1990.

  147. Invited Speaker: Medical Grand Rounds, Good Samaritan Hospital, Lebanon, PA, "The physiology of blood pressure control," April, 1990.

  148. Invited Speaker, plenary program, International Society of Hypertension in Blacks Annual Meeting, Long Beach, CA. "Quality of Life, the cornerstone of antihypertensive management," May 1990.

1   2   3   4   5   6   7


The database is protected by copyright ©dentisty.org 2016
send message

    Main page